Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.9, 2010-09, pp. : 567-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Anti-Xa Monitoring for Low-Molecular-Weight Heparins in Patients with Chronic Kidney Disease

By Gallieni Maurizio

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 773-774

Adis International

Access to resources Recommend Favorite

Synthesis and Anticoagulant Activity of Low-Molecular-Weight Heparins

By Stolbushkina P. P. Bannikova G. E. Drozd N. N. Makarov V. A. Varlamov V. P. Vikhoreva G. A.

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 2, 2004-02 ,pp. : 82-85

Springer Publishing Company

Access to resources Recommend Favorite

Low molecular weight heparins

By Aguilar O.M. Kleiman N.S.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins: Mechanisms, Trials, and Role in Contemporary Interventional Medicine

By Canales John F. Ferguson James J.

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 15-25

Adis International

Access to resources Recommend Favorite

Pulmonary Delivery of Low Molecular Weight Heparins

By Yang Tianzhi Mustafa Fatima Bai Shuhua Ahsan Fakhrul

Pharmaceutical Research, Vol. 21, Iss. 11, 2004-11 ,pp. : 2009-2016

Springer Publishing Company

Access to resources Recommend Favorite